AGORACOM-JC « AGORACOM Small-cap Investor Relations Blog

Author Archive

Kontrol Energy $KNR.ca Presenting at The LD 500 Virtual Investor Conference $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

Posted by AGORACOM-JC at 7:14 AM on Tuesday, August 25th, 2020

CEO Paul Ghezzi will present to investors attending the LD 500 investor conference on Thursday, September 3, 2020 at 10:40am PST / 1:40pm EST.
Mr. Ghezzi will also host one-on-one investor meetings on September 2 and September 4.

LOS ANGELES, CA / August 25, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company“) today announced that CEO Paul Ghezzi will present to investors attending the LD 500 investor conference on Thursday, September 3, 2020 at 10:40am PST / 1:40pm EST. Mr. Ghezzi will also host one-on-one investor meetings on September 2 and September 4.

“Kontrol Energy is addressing a $100 billion annual problem of commercial building energy waste, greenhouse gas emissions, and air quality monitoring,” said Mr. Ghezzi. “As COVID began to impact the operations of our customers, we heard concerns around the aerosolization of the virus and its potential ability to spread indoors. Given our background in monitoring for volatile organic compounds for blue-chip companies across North America, we started to consider a potential solution for detecting COVID in the air. Since March of 2020 we have developed our BioCloud technology prototype, secured government funding that is accelerating the development of BioCloud, and had our first positive lab results. We look forward to discussing these developments and more with investors attending the LD 500 conference.”

View Mr. Ghezzi’s video presentation here: https://www.webcaster4.com/Webcast/Page/2019/36650

To book a meeting, register here: https://ld-micro-conference.events.issuerdirect.com/

“We have been waiting for this moment all year long. Due to COVID, it has been nearly impossible for physical conferences to even take place. I want to show the world that you can still learn, have a great time, and see some of the most unique companies in the capital markets today. All without having to step foot outside. For the first time, LD Micro is accessible to everyone, and we are honored to welcome you to one of the most trusted platforms in the space,” said Chris Lahiji, Founder of LD.

The LD 500 will take place on September 1st through the 4th.

View Kontrol Energy’s profile here: https://www.ldmicro.com/profile/KNR.CN

Profiles powered by LD Micro – News Compliments of Accesswire

About LD Micro

Back in 2006, LD Micro began with the sole purpose of being an independent resource to the microcap world.

What started as a newsletter highlighting unique companies, has transformed into the pre-eminent event platform in the space.

The upcoming “500” in September is the Company’s most ambitious project yet, and the first event that is accessible to everyone.

For those interested in attending, please contact David Scher at [email protected] or visit www.ldmicro.com for more information.

About Kontrol Energy

Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides market-based energy solutions to our customers designed to reduce their overall cost of energy while providing a corresponding reduction in greenhouse gas (GHG) emissions.

Kontrol Energy is one of Canada’s fastest growing companies in 2018 and 2019 as ranked by Canadian Business and Maclean’s.

Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com.

For further information, contact:

Paul Ghezzi, Chief Executive Officer
[email protected] or [email protected]
Kontrol Energy Corp.,
180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8
Tel: 905.766.0400, Toll free: 1.844.566.8123

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.

However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.

Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.

SOURCE: Kontrol Energy Corp. via LD Micro

Tags: BioCloud, COVID-19, CSE, energy conservation, google nest, green energy
Posted in Kontrol Energy Corp. | Comments Off on Kontrol Energy $KNR.ca Presenting at The LD 500 Virtual Investor Conference $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

Loop Insights $MTRX.ca and $KABN.ca North America Partner to Launch #AI Driven Merchant and Consumer Rewards Programs, Secured by #Biometrics and #Blockchain $QUIS.ca $MCLD.ca $NXO.ca

Posted by AGORACOM-JC at 7:11 AM on Tuesday, August 25th, 2020

Announced an initial partnership agreement with KABN Systems North America Inc., a wholly-owned subsidiary of KABN System NA Holding Corp. (CSE: KABN), a Canadian Fintech company that specializes in continuous online identity verification, management and monetization in Canada and the US
As the world goes more digital and more “check-ins” are required for contact tracing purposes, KABN NA can also enhance Loop’s contact tracing check-in solution with its proprietary blockchain technology
The global blockchain market size is expected to grow from USD 3.0 billion in 2020 to USD 39.7 billion by 2025, at an impressive Compound Annual Growth Rate (CAGR) of 67.3% during 2020–2025 (source: www.marketsandmarkets.com).

VANCOUVER, BC and TORONTO, Aug 25, 2020 – Loop Insights Inc. (TSXV: MTRX) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive automated marketing, contact tracing, and contactless solutions to the brick and mortar space, is pleased to announce an initial partnership agreement with KABN Systems North America Inc., a wholly-owned subsidiary of KABN System NA Holding Corp. (CSE: KABN) (“KABN NA” or “KABN North America”), a Canadian Fintech company that specializes in continuous online identity verification, management and monetization in Canada and the US.

TOGETHER, THE COMPANIES WILL CREATE A VERIFIED DIGITAL ID CHECK-IN SYSTEM FOR LARGE SCALE VENUES

As the world goes more digital and more “check-ins” are required for contact tracing purposes, KABN NA can also enhance Loop’s contact tracing check-in solution with its proprietary blockchain technology. The global blockchain market size is expected to grow from USD 3.0 billion in 2020 to USD 39.7 billion by 2025, at an impressive Compound Annual Growth Rate (CAGR) of 67.3% during 2020–2025 (source: www.marketsandmarkets.com).

KABN NA’s Liquid Avatar program increases the security within Loop’s services. Customer information and identities are protected by blockchain technology- the highest level of protection. This identity verification enhancement for Loop comes at a great time. It accelerates conversations with large scale business development opportunities, such as schools, stadiums, and governments that are reopening and seek fast and secure contact tracing check-in platforms.

COMBINATION OF LOOP AND KABN NA TECHNOLOGIES RESULTS IN POWERFUL AND COMPLIANT SOLUTION FOR MERCHANTS

KABN NA, in its simplest form, turns the major problem of data privacy into a profit for individuals by giving them complete control over what data is visible on sites and platforms throughout the web.

In order to deliver this level of control, KABN has created Liquid Avatar, a powerful platform that allows users to create digital icons representing their online personas. An individual can create different Liquid Avatars to share different levels of private data with different facets of their life, such as social media, professional, business, e-commerce, and banking.

Every Liquid Avatar is biometric and blockchain secured.

On the other hand, Loop Insights provides merchants with a turnkey solution, driven by artificial intelligence. This allows them to unlock their bricks and mortar data in real-time to make smarter, faster, data-driven decisions that deliver personalized promotions and targeted engagement—leading to higher conversions and transaction revenue in professional sports, entertainment, and retail industries.

As a result of the partnership that converges the powerful technologies of both Loop and KABN NA, the tremendous value will be created for retailers and e-commerce stores due to transacting with known users who have been biometrically verified identity with a blockchain-enabled digital wallet.

In turn, this will provide merchants with the ability to push, customized offers, promotions, and other incentives based on permission-based data to a known, real person. This is extremely valuable in an environment fraught by bots and fake accounts.

NEW BUSINESS MODELS AND REVENUE STREAMS FULLY COMPLIANT WITH GLOBAL DATA PRIVACY LAWS

Moreover, the combination of these powerful standalone technologies will provide Loop and KABN NA with new business models that are compliant with jurisdictional privacy laws and regulations, where the user has management and control over the data.

KABN NA CEO, Ben Kessler: “We are very excited to partner with Loop to create a more interactive and rewarding experience for consumers. We believe that combining our efforts and solutions builds both a robust data and identity verification platform as well as, a personalized, customer-first loyalty solution. We look forward to leveraging all of these enhanced capabilities to expand our retail client and brand partner opportunities.”

Loop CEO Rob Anson: “The convergence of Loop’s IoT and AI technology with KABN NA’s Blockchain and digital identity platform is compelling and will lead to many new possible global revenue opportunities. This exciting partnership unlocks potential new ways for us to monetize our services, expand our client networks, and further accelerate our pursuit on a global scale.”

PARTNERSHIP UNLOCKS NEW WAYS FOR LOOP TO FURTHER MONETIZE ITS INSIGHTS AND ENGAGEMENT PLATFORM THROUGH RETAIL CLIENTS AND BRAND PARTNERS

Under the partnership, Loop will participate in potential revenue generated from KABN NA’s Liquid Avatar program, which includes a percentage of the sign-ups, commissions, and service fees that KABN generates from brands, retailers, other businesses, and affiliates. Loop intends to leverage brand and corporate interest to gain revenue from its third-party programmatic advertising platform.

Combining Loop’s AI-powered retail analytics and engagement with KABN’s Liquid Avatar digital identity platform, KABN KASH, a cashback and loyalty engine, and the KABN Visa card program, the partnership will create new revenue-generating opportunities for Loop. In addition to Loop’s current engagement service offerings, Loop will now be able to offer KABN KASH (cashback and rewards) and the KABN Card to its growing base of retailers and in so doing, expand its monetization efforts, while also growing its base of users and user-generated data.

This Press Release Is Available On The Loop Insights Verified Forum On AGORACOM For Shareholder Discussion and Q&A https://agoracom.com/ir/LoopInsights/forums/discussion

About KABN North America –www.kabnnaholdco.com

KABN Systems NA Holdings Corp. through its wholly owned subsidiary KABN Systems North America Inc. focuses on the verification, management and monetization of digital identity, empowering users to control and benefit from its use of their online identity.

KABN propriety technology suite includes 4 key products:

Liquid Avatar allows users to create high quality digital icons representing their online personas. These icons, in conjunction with KABN ID, allows users to manage and control their Digital Identity and to use Liquid Avatars to share public and permission based private data when they want and with whom they want. www.liquidavatar.com

KABN ID is an Always On, biometric and blockchain based digital identity validation and verification platform allowing users to continuously and confidently prove themselves throughout the online community.

KABN Card is a Visa approved prepaid card program allowing users to manage both digital and fiat currencies and earn cashback and other loyalty incentives. www.kabncard.com

KABN KASH is a cashback, loyalty and engagement program that powers the KABN revenue ecosystem.

KABN provides its products and services at no cost to consumers and generates revenues through permission-based partner programs. www.kabnkash.com

For more information, please visit www.kabnnaholdco.com or www.kabnsystemsna.com

About Loop Insights: Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia.

The TSXV and CSE have not reviewed and do not accept responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities in the United States.

Forward-Looking Information and Statements
This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only LOOP and KABN NA beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of LOOP and KABN NA’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include, but is not limited to, information concerning the ability of LOOP and KABN NA to generate revenues, roll out new programs and to successfully achieve business objectives, and expectations for other economic, business, and/or competitive factors.

By identifying such information and statements in this manner, LOOP and KABN NA are alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, LOOP and KABN NA have made certain assumptions. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

Although LOOP and KABN NA believe that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and LOOP and KABN NA do not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward- looking information and statements attributable to LOOP and KABN NA or persons acting on its behalf is expressly qualified in its entirety by this notice.

SOURCE LOOP Insights Inc.

Tags: AI, covid19, Covid19 tracing, CSE, internet of things, IOT, tsx-v
Posted in KABN, KABN Systems NA Holdings Corp., Loop Insights Inc. | Comments Off on Loop Insights $MTRX.ca and $KABN.ca North America Partner to Launch #AI Driven Merchant and Consumer Rewards Programs, Secured by #Biometrics and #Blockchain $QUIS.ca $MCLD.ca $NXO.ca

Empower Clinics $CBDT.ca Reports Q2 2020 Results with 56% Revenue Increase and YTD 2020 with 130% Revenue Increase $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 7:03 AM on Tuesday, August 25th, 2020

6,696 patient visits generating total revenue of $923,876, compared to 4,299 patient visits generating $591,023 for Q2 2019

VANCOUVER, BC / ACCESSWIRE / August 25, 2020 / EMPOWER CLINICS INC. (CSE:CBDT)(OTCQB:EPWCF) (Frankfurt:8EC) (“Empower” or the “Company“) has filed today its unaudited condensed interim financial statements and related management’s discussion and analysis, both of which are available at www.SEDAR.com. All financial information in this press release is reported in United States dollars, unless otherwise indicated.

“Execution, operational excellence and a passion for patient care highlights a transformative quarter, in the midst of a pandemic.” said Steven McAuley, Chairman and CEO. “Our team continues to outperform, delivering triple digit first-half 2020 growth, with continued diversification of services, setting in motion our ongoing path of growth.”

Q2 2020 Highlights

6,696 patient visits generating total revenue of $923,876, compared to 4,299 patient visits generating $591,023 for Q2 2019.
Net loss of $401,110 or $0.00 per share, compared to $1,456,506 or $0.01 per share for Q2 2019, driven by significantly reducing operating costs through aggressive headcount cuts and facility changes and a reduction in legal and professional fees and non-cash share-based payments.
Cash used in operating activities was $11,187, compared to $1,112,738 for Q2 2019.
Cash at June 30, 2020 of $305,935, compared to cash of $179,152 at December 31, 2019.

YTD 2020 Highlights

12,413 patient visits generating total revenue of $1,713,011, compared to 5,497 patient visits generating $743,869 for six months ended June 30, 2019.
Net loss of $920,281 or $0.01 per share, compared to $1,855,047 or $0.02 per share for six months ended June 30, 2019, driven by significantly reducing operating costs through aggressive headcount cuts and facility changes and a reduction in legal and professional fees and non-cash share-based payments.
Cash provided by in operating activities was $2,647, compared to cash used in operating activities of $1,331,950 for six months end June 30, 2019.

Financial Summary

$, except where noted	Three months ended June 30,			Six months ended June 30,
	2020			2019		2020	2019
Patient visits (#)		6,696			4,299		12,413		5,497
Clinic Revenues		923,876			591,023		1,713,011		743,869
Direct Clinic Expenses		243,905			82,750		512,305		122,163
Loss from operations		(240,614	)		(1,424,071	)	(558,446	)	(1,703,379	)
Net loss		(401,110	)		(1,456,506	)	(920,281	)	(1,855,047	)
Net loss per share		(0.00	)		(0.01	)	(0.01	)	(0.02	)

Financial Performance

Clinic revenues for Q2 2020 and Q2 2019 were $923,876 and $591,023, respectively. This increase above prior year is attributable to the acquisition of Sun Valley and the addition of 5 clinics which drove an increase in patient count from 4,299 in Q2 2019 to 6,696 in Q2 2020.

Direct clinic expenses for Q2 2020 and Q2 2019 were $243,905 and $82,750, respectively. This increase above prior year is attributable to the increase in number of patient visits.

Loss from operations for Q2 2020 and Q2 2019 were $240,614 and $1,424,071, respectively. This decrease in net loss from operations below prior year is primarily attributable to an increase in clinic profitability with the acquisition of Sun Valley and a decrease in salaries and benefits, legal and professional fees and non-cash share-based payments expense.

Net loss for Q2 2020 and Q2 2019 were $401,110 and $1,456,506, respectively. This decrease below prior year is primarily attributable to non-cash accretion expense related to the convertible debentures and the positive impact of the Sun Valley acquisition.

During the six months ended June 30, 2020, the Company generated $2,647 in cash from operations after changes in non-cash working capital.

Please refer to the Company’s unaudited condensed interim consolidated financial statements for the three and six months ended June 30, 2020 and 2019, and accompanying Management Discussion and Analysis for a full review of the operations.

About Empower

Empower is a vertically integrated health & wellness company with a network of corporate and franchised health & wellness clinics in the U.S. The Company is focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has launched Dosed Wellness Ltd. to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies, psilocybin and other psychedelic plant-based treatment options.

ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley
Chief Executive Officer

CONTACTS:

Investors	Dustin Klein	Steven McAuley
	Director	CEO
	720-352-1398	604-789-2146
	[email protected]	[email protected]

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include, but are not limited to, statements regarding the direction and growth prospects of the Company, the expansion of the company’s clinic and distribution network, the expected effect of the Vendors in their new roles with the Company, the effect on the lives of patients, the growth into a national brand, the effect of the Transaction, the diversification of the Company’s business model, the potential appeal to shareholders, the growth of the Company’s patient list and the effect thereof, the expected benefits for the company’s patient base and customers, the release of the cash consideration, the release of Shares being held in escrow in connection with the Transaction and statements regarding the Company’s proprietary product line “Sollievo”. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including that the Company may not be able to expand, that the Transaction may not have the expected results, and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

SOURCE: Empower Clinics Inc.

Posted in Empower Clinics Inc., Featured | Comments Off on Empower Clinics $CBDT.ca Reports Q2 2020 Results with 56% Revenue Increase and YTD 2020 with 130% Revenue Increase $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

PyroGenesis $PYR.ca Comments on Recent Trading Activity; Military, Tunneling, Drosrite, Pelletization, PUREVAP; All on Track $RTN $NOC $UTX $DDD.ca $SSYS $PRLB

Posted by AGORACOM-JC at 2:13 PM on Monday, August 24th, 2020

Company wishes to reassure investors that all projects (Military, Tunneling, Drosrite™, Pelletization, PUREVAP™, etc…) are all on track and there are no undisclosed events to warrant this morning’s decline.
Everything material has been disclosed by the Company in either its press releases or financial reports. PyroGenesis further confirms that none of the contracts press released are at risk.
Last but not least, the Company wishes to reassure PyroGenesis’ shareholders that we remain on track with our current and prospective projects.

MONTREAL, Aug. 24, 2020 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, issues this press release in response to this morning’s trading activity, and the sudden decline in its stock price. The Company wishes to reassure investors that all projects (Military, Tunneling, Drosrite™, Pelletization, PUREVAP™, etc…) are all on track and there are no undisclosed events to warrant this morning’s decline.

The Company does not usually opine on stock price and trading activity, however, given the recent decline, and inquiries from investors, the Company confirms the following:

Everything material has been disclosed by the Company in either its press releases or financial reports. PyroGenesis further confirms that none of the contracts press released are at risk. Last but not least, the Company wishes to reassure PyroGenesis’ shareholders that we remain on track with our current and prospective projects.

“I just wanted to take the time to reassure investors that the precipitous decline in stock price today cannot be explained by any undisclosed developments at the Company,” said Mr. P. Peter Pascali, CEO and President of PyroGenesis. “To the contrary, all of our projects are moving ahead and are closer to completion than before. The potential contracts previously announced are not in jeopardy and are moving ahead. Regretfully, to those looking from the outside, it always seems to take longer than expected, however, nothing can be further from the truth and, in certain instances, are proceeding with lightning speed particularly given the entities we are talking to and the significance of the contracts under discussion.”

About PyroGenesis Canada Inc.

PyroGenesis Canada Inc., a high-tech company, is the world leader in the design, development, manufacture and commercialization of advanced plasma processes and products. We provide engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, advanced materials (including 3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Our core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Our operations are ISO 9001:2015 and AS9100D certified, and have been since 1997. PyroGenesis is a publicly-traded Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws. Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.
For further information please contact:
Rodayna Kafal, Vice President Investors Relations and Strategic Business Development,
Phone: (514) 937-0002, E-mail: [email protected]

RELATED LINK: http://www.pyrogenesis.com/

Tags: drosrite, plasma, powders, PUREVAP, PyroGenesis
Posted in PyroGenesis Canada Inc. | Comments Off on PyroGenesis $PYR.ca Comments on Recent Trading Activity; Military, Tunneling, Drosrite, Pelletization, PUREVAP; All on Track $RTN $NOC $UTX $DDD.ca $SSYS $PRLB

CLIENT FEATURE: Innocan Pharma $INNO.ca Developing The #Pharmaceutical Guided Missile To Defeat #Coronavirus Lung Infections $GWPH $CRDL.ca $TEVA

Posted by AGORACOM-JC at 1:54 PM on Monday, August 24th, 2020

InnoCan – Developing The Pharmaceutical Guided Missile To Defeat Coronavirus Lung Infections

InnoCan Pharma Is A Pharmaceutical Company That Specializes In The Development Of New Drug Platforms Which Combine Unique Properties of Cannabinoids

WHY INNOCAN?

InnoCan has 3 fully operating divisions to address the market for Cannabis products. As a Cannabis investor, why limit yourself to a Company with just one specialty, when InnoCan offers you exposure to both the exploding world of cannabis pharma, as well as, a portfolio of patent-pending and launch ready consumer health products.

PHARMACEUTICAL – THE GUIDED MISSILE

Revolutionary Technology Targeting Lungs Infected With Coronavirus or other viral infections
- Done By Combining CBD with Stem Cell Particles (Exosomes)
- Research & Licensing Agreement with Tel Aviv University
Developing CLX, The ICBM Ballistic Missile Of Coronavirus Lung Infections
Separate breakthrough delivery and control release technology that enables the injection of CBD.

CONSUMER RETAIL – DERMA COSMETICS

A Premium Derma Cosmetics Brand
Containing Highly Concentrated Ingredients Formulated with CBD
Manufacturing & Supply Agreements – Europe and United States
Manufacturing Has Commenced For 9 Products As Of Q2 2020
Distribution Agreements – United Kingdom and Ireland

Company entered into a distribution agreement (with a Swiss CBD provider called Cloud 9 Switzerland LLC to sell the Company’s SHIRTM Beauty and Relief & Go product lines in Italy and Switzerland.

OVER THE COUNTER (OTC) PRODUCTS FOR PAIN RELIEF

Patent-Pending CBD Pain Relief Brand
Versions Include Spray, Roll-On and Cream
Relief & Go Spray – First Product Being Manufactured
- FDA Technical Validation
- FDA Approval To Commence Marketing In The United States
Manufacturing Commencement
- New Jersey (United States Market)
- Portugal (Asia and Europe Markets)
Sales Commence In H2 2020

SUPERIOR MANAGEMENT TEAM

The InnoCan Leadership Group Is Incomparable In The Small Cap World
Comprised Of Leading Israeli Pharmaceutical Executives
Executive Chairman (Ron Mayron) was the CEO Of Teva Israel, one of the largest generic pharmaceutical companies in the world
Co-Founder & VP Business Development (Yoram Drucker) was the Founder of 2 NASDAQ Companies (Pluristem & Brainstorm)
Chief Technology Officer (Nir Avram) is a former member of the pharma innovation team at Perrigo, producer of OTC consumer goods and specialty pharma.
Chief Executive Officer (Iris Bincovich) has a proven track record in opening global markets, having managed hundreds of successful transactions in OTC, cosmetics and dermatology.
Together they have built a formidable team at InnoCan

SEEING IS BELIEVING

FULL DISCLOSURE: Innocan Pharma is an advertising client of AGORA Internet Relations Corp.

Tags: CBD, CBD Derma Cosmetics, CBD stocks, CSE, Innocan, Relief & Go Pain Relief Spray, SHIR
Posted in All Recent Posts, Featured, Innocan Pharma Corporation | Comments Off on CLIENT FEATURE: Innocan Pharma $INNO.ca Developing The #Pharmaceutical Guided Missile To Defeat #Coronavirus Lung Infections $GWPH $CRDL.ca $TEVA

betterU $BTRU.ca Launches European Operations $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 9:56 AM on Monday, August 24th, 2020

betterU completes incorporation of betterU Europe Inc.
betterU launches Europe SaaS B2B platform

OTTAWA, ON / August 24, 2020 / betterU Education Corp. (TSX VENTURE:BTRU) (Frankfurt:5OGA) (the “Company” or “betterU”) is pleased to announce the successful launch of betterU Europe Inc. (BUI), a wholly-owned subsidiary of the Company, based in Dublin, Ireland. BUI has been established to facilitate and support a growing level of interest for online learning across European countries.

The e-learning market in Europe is poised to grow by $ 24.23 billion during 2020-2024 progressing at a CAGR of 12% during the forecast period. The market is driven by the availability of subject proficiency assessments and certifications and a rise in adoption of digital platform-enabled education.

BUI will also support several initiatives current under development including opportunities for non-dilutive investment and EU subsidies as well as several possible strategic partnerships. The Company has also recently launched https://betteruskills.com/en/ as part of its marketing efforts to support awareness and access to BUI services for European companies.

About betterU Education Corp.

betterU is an education-to-employment technology company offering an end-to-end solution leveraging business intelligence to automate skilling, reskilling and upskilling for companies operating on domestic and global scales. The Company supports the industry by providing them with everything an organization needs to launch and manage proper skills development programs so that they can focus on what really matters, their people!

Most companies spent too much time trying to source, integrate, customize and deliver fragmented skills development programs across their organization, when they should be focused solely on supporting their people. betterU’s integrated platform brings together the right technology, growing content library, customization, language options and is the most efficient affordable solution on the market. We don’t sell content, we help build better people.

For more information, please visit https://corporate.betteru.ca/corporate-gov/

Contact:

Brad Loiselle, CEO
1-613-695-4100
[email protected]

betterU Education Corp.
Investor Relations
Email: [email protected]

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Tags: Byju, COVID-19, CSE, edtech, india, small cap stocks
Posted in betterU Education Corp | Comments Off on betterU $BTRU.ca Launches European Operations $ARCL $CPLA $BPI $FC.ca

Hollister Biosciences Inc. $HOLL.ca Reports Second Quarter 2020 Results With $8.47 Million In Revenue $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 8:25 AM on Monday, August 24th, 2020

https://prnewswire2-a.akamaihd.net/p/1893751/sp/189375100/thumbnail/entry_id/1_dd2snc3b/def_height/400/def_width/400/version/100011/type/1

Multi-state operator and diversified cannabis branding company generates record quarterly revenue and delivers profitable second quarter

Revenue generated for the three-month period ended June 30th, 2020 was $8.47 million versus $0.2 million from the second quarter last year, representing significant year over year revenue growth
Revenue was primarily generated from the sale of concentrates, pre-rolls and contract manufacturing services

VANCOUVER, BC, Aug. 24, 2020 – Hollister Biosciences Inc. (CSE: HOLL), (OTC: HSTRF), (FRANKFURT: HOB) (the “Company“, “Hollister Cannabis Co.” or “Hollister“) a diversified cannabis branding company with products in over 230 dispensaries throughout California, and over 80 dispensaries throughout Arizona, announces financial results for the second quarter 2020 (ended June 30th, 2020). All figures in US Dollars unless otherwise stated.

Second Quarter Financial Highlights

Revenue generated for the three-month period ended June 30th, 2020 was $8.47 million versus $0.2 million from the second quarter last year, representing significant year over year revenue growth
Revenue was primarily generated from the sale of concentrates, pre-rolls and contract manufacturing services
Net income for the three-month period ended June 30th, 2020 was $0.3 million compared to a net loss of $2.1 million in the first quarter of 2020

“Our second quarter results are encouraging and in line with our objective to increase revenue and profitability” shared Alex Somjen, President of Hollister Biosciences Inc. “These financial results are a product of increased brand awareness, strategic M&A and strategic partnerships put in place over the previous six months.”

Operational Highlights and Strategic Objectives for 2020

The challenges presented by the COVID-19 pandemic have accelerated Hollister’s plans to roll out direct to consumer delivery
- The brand will be called “Dreamy Delivery” and the first delivery hub is expected to launch in the fourth quarter of 2020 with statewide delivery anticipated by the end of 2021
Design and build-out of Hollister’s 100% owned subsidiary, Venom Extracts, in the Company’s Hollister, CA facility are underway
Product development and product launch associated with the Company’s joint venture with Tactical Relief and the Company’s 100% owned subsidiary, Alpha Mind Brands Inc., respectively, are progressing
The Company’s partnership with Tommy Chong’s Cannabis is progressing well, with Tommy Chong’s Full Spectrum Elixir now being distributed in 20 dispensaries throughout the state of California by Hollister’s distribution partner Indus Holdings Inc. (CSE: INDS)

“Enormously proud of our teams in Arizona & California. Our staff continues to overcome obstacles like the global pandemic while posting record revenue numbers. We look forward to continuing to execute on our plans while increasing value for our shareholders.” Said Carl Saling CEO of Hollister Biosciences.

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products. Our wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker”.

Website:www.hollistercannabisco.com

The CSE, nor its regulation services provider, does not accept responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/hollister-biosciences-inc-reports-second-quarter-2020-results-301116831.html

SOURCE Hollister Biosciences Inc.

Tags: budder, Cannabis, CBD, CSE, hash, hashbone, Hemp, mushrooms, pre-roll, small cap
Posted in All Recent Posts, Featured, Hollister Biosciences | Comments Off on Hollister Biosciences Inc. $HOLL.ca Reports Second Quarter 2020 Results With $8.47 Million In Revenue $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Esports Entertainment Group $GMBL to Present at The LD 500 Virtual Conference $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca $TRWH

Posted by AGORACOM-JC at 8:20 AM on Monday, August 24th, 2020

Announced that its CEO Grant Johnson will be presenting at the LD 500 investor conference on Tuesday, September 1, 2020 at 9:20 a.m. EDT.
“We’ve achieved multiple key milestones since our listing on NASDAQ in April, and I look forward to sharing with the LD conference attendees more about these successes and what it means for the future of the Esports Entertainment Group,” commented Grant Johnson, CEO.

BIRKIRKARA, MALTA / August 24, 2020 / Esports Entertainment Group, Inc. (NASDAQ:GMBL)(NASDAQ:GMBLW) ( the “Company”), a licensed online gambling company with a focus on esports wagering and 18+ gaming, today announced that its CEO Grant Johnson will be presenting at the LD 500 investor conference on Tuesday, September 1, 2020 at 9:20 a.m. EDT.

“We’ve achieved multiple key milestones since our listing on NASDAQ in April, and I look forward to sharing with the LD conference attendees more about these successes and what it means for the future of the Esports Entertainment Group,” commented Grant Johnson, CEO.

Register here: https://ld500.ldmicro.com/

The LD 500 will take place on September 1st through the 4th.

View Esports Entertainment Group’s profile here: http://www.ldmicro.com/profile/GMBL

About Esports Entertainment Group

Esports Entertainment Group, Inc. is a licensed online gambling company with a specific focus on esports wagering and 18+ gaming. Esports Entertainment offers fixed odds wagering, fantasy and pools on various esports events in a licensed, regulated and secure platform at vie.gg and owns and operates online sports book, SportNation.bet. In addition, Esports Entertainment intends to offer users from around the world the ability to participate in multiplayer mobile and PC video game tournaments for cash prizes. Esports Entertainment is led by a team of industry professionals and technical experts from the online gambling and the video game industries, and esports. The Company holds a license to conduct online gambling and 18+ gaming on a global basis in the UK, Ireland, Malta and Curacao. The Company maintains offices in New Jersey, the UK and Malta. For more information visit www.esportsentertainmentgroup.com.

FORWARD-LOOKING STATEMENTS

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.

Contact:

U.S. Investor Relations
RedChip Companies, Inc.
Dave Gentry
407-491-4498
[email protected]

Media & Investor Relations Inquiries
AGORACOM
[email protected]
http://agoracom.com/ir/eSportsEntertainmentGroup

SOURCE: Esports Entertainment Group, Inc.

Tags: Activision Blizzard, Apple, Draftkings Inc, EA sports, egaming, esports, nasdaq
Posted in Esports Entertainment Group, Esports Entertainment Group Inc. | Comments Off on Esports Entertainment Group $GMBL to Present at The LD 500 Virtual Conference $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca $TRWH

Avicanna $AVCN.ca Advances its Supply Chain Business with Commercial Exports of #CBG And #CBD into the United States and Germany as well as Industrial Scale #THC Quota Granted by the Colombian Authorities $KHRN.ca $TRUL.ca $VFF.ca

Posted by AGORACOM-JC at 8:17 AM on Monday, August 24th, 2020

http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg

The export of the CBG isolates into the United States is part of the first known industrial cultivation, extraction, and purification of cannabigerol (“CBG”) in Colombia, validating the Company’s early mover advantage in proprietary genetics, extraction, and high margin input materials.
The commercial THC cultivation quota for 11,587 psychoactive plants will be used for commercial production of THC derivatives for exports.
The group of exports into the United States were also piloted as a part of a global tracking system through StrainSecure™, a brand of TruTrace Technologies.

TORONTO, Aug. 24, 2020 – Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products announces that through its majority owned subsidiary, Santa Marta Golden Hemp S.A.S. (“SMGH“), the company has completed exports of CBG and CBD isolates into the United States, CBD isolate into Germany and the commencement of a pilot tracking system for the export of its active pharmaceutical ingredient (“API“) products in partnership with TruTrace Technologies Inc. (“TruTrace“) (CSE: TTT) (OTCQB: TTTSF). The Company is also pleased to announce that the Colombian Ministry of Justice and Law has granted SMGH a commercial and industrial cultivation quota for 12,264 THC plants by.

The export and sale of the commercial lot of isolated CBG into the United States was completed in parallel with commercial export of isolated CBD into the United States, as well as a pilot export for R&D purposes of CBD into Germany. The cultivation, extraction and purification of these cannabinoids including the rare cannabinoid, CBG, were all completed through Avicanna’s vertical integration at SMGH and validate the company’s innovation and leadership in natural rare cannabinoid production. The products are part of the Aureus™ product portfolio that now includes feminized seeds and advanced formulations as well as CBD, CBG and THC API products.

“This is another massive accomplishment for our team in Colombia as we enter the largest market in the world for non-psychoactive cannabinoids with our proprietary CBG offering. As the cannabinoid-derived products sector continues to evolve, our Aureus branded portfolio continues to advance in order to cater to the needs of our cosmetics and pharmaceutical partners, which require an innovative, credible, thoroughly-tested, organic, sustainable and economical source of input materials. Additionally, with the support of TruTrace, the Aureus products will be provided with traceability and trackability all the way back to the seed through a secured blockchain system.” – Aras Azadian, Chief Executive Officer of Avicanna.

The Colombian Ministry of Justice and Law granted SMGH a supplementary cultivation quota to cultivate 12,264 psychoactive cannabis plants. 11,587 plants will be destined to produce dry flower which will then be used to manufacture psychoactive derivatives for commercial production for export. The remaining 677 plants will be utilized for psychoactive derivatives for the purposes of research and development and pilot production of Avicanna’s RHO Phyto™ branded products in Colombia.

Lucas Nosiglia, President of Avicanna LATAM commented: “This achievement took years of characterization, evaluation and planning which will finally allow Avicanna to produce our THC products and export THC derivatives to our international partners. As one of the only companies permitted to produce THC commercially for the global market, we can focus on less competitive and high margin products.”

To the knowledge of the Company, it carries out its operations in compliance with all applicable laws in the jurisdictions in which it operates.

About StrainSecure™ by TruTrace

Designed specifically by TruTrace for the cannabis industry, StrainSecure™ is a fully integrated software platform, secured on blockchain which aggregates and authenticates all testing and quality assurance data on products and verifies the quality of each batch and lot in distribution. Furthermore, this deployment will mark the first utilization by TruTrace of the OrionOne™ global freight and logistics solution in the cannabis sector thereby providing dynamic visibility of verified Aureus products through the entire international shipping process.

About Avicanna

Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments.

Avicanna is an established leader in cannabinoid research and development, which it primarily conducts at its R&D headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto, Canada and in collaboration with leading Canadian academic and medical institutions. In addition to its developing pharmaceutical pipeline, Avicanna’s team of experts have developed and commercialized several industry leading product lines, including:

Pura H&W™: an advanced and clinically tested line of CBD consumer derma-cosmetic products; and,
RHO Phyto™: an advanced line of medical cannabis products containing varying ratios of CBD and THC currently available nation-wide across Canada in partnership with Medical Cannabis by Shoppers™, a subsidiary of Shoppers Drug Mart. RHO Phyto is the first strictly medical formulary of advanced “Cannabis 2.0” products, containing oils, sprays, capsules, creams, and gels, all developed with scientific rigour, manufactured under GMP standards and supported by pre-clinical data.

With ongoing clinical trials on its derma-cosmetic (Pura H&W), medical cannabis (RHO Phyto) and a pipeline of pharmaceutical products, Avicanna’s dedication to researching the important role that cannabinoids play in an increasingly wider scope of products has been at the core of the Company’s vision since its inception. Furthermore, Avicanna’s commitment to education is demonstrated through its annual medical symposium, the Avicanna Academy educational platform, and the My Cannabis Clinic patient program through its subsidiary company.

Avicanna manages its own supply chain including cultivation and extraction through its two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia. Through these sustainable, economical, and industrial scale subsidiaries, Avicanna cultivates, processes, and commercializes a range of cannabis and hemp cultivars dominant in CBD, CBG, THC, and other cannabinoids for use as active pharmaceutical ingredients. Avicanna’s Avesta Genetica program specializes in the development and optimization of rare cultivars for commercial production along with feminized seeds for global export. In June 2020, Avicanna made history with a shipment of hemp seeds to the United States of America by completing the first ever export of hemp seeds from Colombia.

Stay Connected

For more information about Avicanna, visit www.avicanna.com, call 1-647-243-5283, or contact Setu Purohit, President by email at [email protected].

Cautionary Note Regarding Forward-Looking Information and Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions, and includes statements with respect to the ability of SMGH to continue to complete exports of CBD and CBG isolates to the United States and Germany, SMGH’s ability to continue selling CBD and CBG isolates in the United States and Germany, SMGH’s ability to make use of the supplementary cultivation quota granted by the Colombian Ministry of Justice and Law, the ability of the Company to produce THC products using API produced by SMGH, and the ability of SMGH to export THC derivatives internationally. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits.

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to current and future market conditions, including the market price of the common shares of the Company, and the risk factors set out in the Company’s annual information form dated April 15, 2020, filed with the Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com.

The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

Tags: cannabinoids, CSE, Marijuana, Medical Cannabis by Shoppers, Rho Phyto
Posted in Avicanna Inc., Featured | Comments Off on Avicanna $AVCN.ca Advances its Supply Chain Business with Commercial Exports of #CBG And #CBD into the United States and Germany as well as Industrial Scale #THC Quota Granted by the Colombian Authorities $KHRN.ca $TRUL.ca $VFF.ca

University of Pittsburgh Joseph M. Katz Graduate School of Business Selects ImagineAR $IP.ca $IPNFF as Partner in New MBA Course $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Posted by AGORACOM-JC at 7:19 AM on Monday, August 24th, 2020

http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg

Announced the Joseph M. Katz Graduate School of Business at the University of Pittsburgh is unveiling a new and exciting business disruption series course called, “Augmented and Virtual Reality (AR/VR) for Brands and Strategy.”
The course, in partnership with ImagineAR will be taught by Vanitha Swaminathan, Thomas Marshall Professor of Marketing. “Augmented and Virtual Reality for Brands and Strategy” will be initially available for MBA and MS students and eventually to undergraduate students at the College of Business Administration

VANCOUVER, BC and ERIE, PA, Aug. 24, 2020 – ImagineAR (CSE: IP) (OTCQB: IPNFF) an Augmented Reality Company that enables sports teams, retailers and brands to create their own instant mobile phone AR campaigns, is pleased to announce the Joseph M. Katz Graduate School of Business at the University of Pittsburgh is unveiling a new and exciting business disruption series course called, “Augmented and Virtual Reality (AR/VR) for Brands and Strategy.”

The course, in partnership with ImagineAR will be taught by Vanitha Swaminathan, Thomas Marshall Professor of Marketing. “Augmented and Virtual Reality for Brands and Strategy” will be initially available for MBA and MS students and eventually to undergraduate students at the College of Business Administration. The entirety of the course will be taught in an online format. U.S. News & World Report has ranked the Katz Graduate School of Business 39th in its 2021 ranking of the Best Business Schools in the United States.

During the span of the course, students will work in teams to identify how to apply augmented and virtual reality to a real business or company and to design a branding campaign. To conclude the course, students will present a 10-minute video showcasing their ideas.

“We’re thrilled to introduce the new series of business disruption courses,” said Sara Moeller, Associate Dean for Graduate Programs. “Augmented and Virtual Reality for Brands and Strategy, the inaugural course, is the first step in many new and exciting game-changing courses to come.”

AR/VR technologies have the potential to have a transformational role in how students learn, how managers make decisions and how consumers interact with products and branded experiences. Every business today is required to have an augmented reality strategy in order to unlock creative potential inherent in various touchpoints and user interfaces.

“The offering of this course is extremely unique and timely,” said Swaminathan. “The current health crisis has required marketers to be even more creative in how to engage fans and customers. Augmented and virtual reality tools will provide new, creative ways of engaging with customers during this challenging period of social distancing.”

Alen Paul Silverrstieen, CEO & President of Imagine AR stated, “The adoption of the AR/VR course by the esteemed Joseph M. Katz Graduate School of Business is a real testament to ImagineAR. The school has identified ImagineAR as an industry leader and AR as an enormous opportunity for brands to engage customers during these times where traditional methods would not suffice. I look forward to working with Professor Swaminathan on this revolutionary course work.”

The course will tie into a new case competition, Katz Augmented Reality Case Competition (ARCC), co-sponsored by the Center for Branding, Katz Marketing Club, Katz Technology Club, and ImagineAR. Katz graduate students will compete in teams of four to showcase their futuristic and creative ideas for how products and brands can become more innovative in the future. The Katz ARCC will provide an important way for students to gain exposure to AR/VR technologies and will challenge them to think through the various ways in which it can improve the brand experience.

To learn more about the Augmented and Virtual Reality for Brands and Strategy course, click this link.

About ImagineAR

ImagineAR Inc. (CSE: IP) (OTC: IPNFF) is an augmented reality (AR) platform, ImagineAR.com, that enables businesses of any size to create and implement their own AR campaigns with no programming or technology experience. Every organization, from professional sports franchises to small retailers, can develop interactive AR campaigns that blend the real and digital worlds. Customers simply point their mobile device at logos, signs, buildings, products, landmarks and more to instantly engage videos, information, advertisements, coupons, 3D holograms and any interactive content all hosted in the cloud and managed using a menu-driven portal. Integrated real-time analytics means that all customer interaction is tracked and measured in real-time. The AR Enterprise platform supports both IOS and Android mobile devices and upcoming wearable technologies.

All trademarks of the property of respective owners.

ON BEHALF OF THE BOARD

Alen Paul Silverrstieen
President & CEO
(818) 850-2490
https://twitter.com/IPtechAR
https://www.facebook.com/imaginationparktechnologies
https://www.instagram.com/iptechar
https://www.linkedin.com/company/imagination-park-technologies-inc

We encourage you to do your own due diligence and ask your broker if ImagineAR Inc. (cse: IP) is suitable for your particular investment portfolio*.

The Canadian Securities Exchange has neither approved nor disapproved the contents of this press release. This press release may include ‘forward-looking information’ within the meaning of Canadian securities legislation, concerning the business of the Company. The forward looking information is based on certain key expectations and assumptions made by ImagineAR Inc. management. Although ImagineAR believes that the expectations and assumptions on which such forward- looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because ImagineAR can give no assurance that it will prove to be correct. These forward-looking statements are made as of the date of this press release, and ImagineAR disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

SOURCE ImagineAR

Tags: Apple, AR, augmented reality, Camerai, CSE, small cap, stocks, tsx
Posted in Imagine AR | Comments Off on University of Pittsburgh Joseph M. Katz Graduate School of Business Selects ImagineAR $IP.ca $IPNFF as Partner in New MBA Course $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Author Archive

Categories